课题基金 / 基金详情

Vascular Surgery: Research Training in Vascular Biology

Vascular Surgery: Research Training in Vascular Biology
血管外科:血管生物学研究培训
批准号:
8969686
负责人:
PETER K HENKE
金额:
$14.68万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2019-11-30

项目摘要

项目成果

PETER K HENKE的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):血管生物学和心血管科学的研究正在迅速发展。然而,与此同时,医生科学家有越来越多的临床责任,他们必须亲自参加,以满足报销保险要求。此外,随着人口老龄化,血管疾病患者的数量也在增加。因此,用于血管生物学和心血管科学研究的时间更少,推进这一学科的医生科学家也更少。在这种背景下,很明显,血管生物学和心血管科学研究的适当培训对于那些将在未来十年内成为我们领域领导者的医生科学家至关重要。 目前的提案是成功的T-32计划的延续,该计划提供血管生物学研究培训,现已完成10年的“血管外科:血管生物学研究培训”。该计划为医学博士学员提供基础科学/转化科学课程,或卫生服务成果科学课程。该计划的一个巨大优势是两个课程之间的交叉施肥与两个途径的培训的共同要素。培训集中在新的北校区研究中心(NCRC)和密歇根大学塞缪尔和让弗兰克尔心血管中心。北校区的研究综合体是独一无二的,拥有密歇根大学的资源和关键的科学核心设施,NCRC的环境是专门为促进合作和 创新NCRC拥有28栋建筑,包括210万平方英尺的办公室,研究和制造空间,于2009年从辉瑞收购。心血管中心于2007年开业,将心血管疾病护理和治疗中的所有初级服务本地化。该计划的教师来自多个学科,包括血管外科,普通外科,心脏外科,内科,心血管医学,急诊医学,人类遗传学和病理学。除了受训者与项目学院的个别科学家密切合作外,该提案还包括教学内容。 该计划的共同点是强调血管生物学和心血管科学的研究,最终目标是为学术血管生物学和心血管科学提供下一代领导者。
英文摘要
 DESCRIPTION (provided by applicant): Research in vascular biology and cardiovascular science is rapidly progressing. At the same time, however, physician scientists have increasing clinical responsibilities which they must personally attend to in order to fulfill reimbursement an insurance requirements. Additionally, with the aging of the population, the number of patients with vascular disease is increasing. Thus, there is less time for research in vascular biology and cardiovascular science and fewer physician scientists are advancing the discipline. With this background, it is clear that proper training in research in vascular biology and cardiovascular science is critical for those physician scientists who will be the leaders in our field over the net decade(s). The current proposal is a continuation of the successful T-32 program providing research training in vascular biology, now completing 10 years in existence "Vascular Surgery: Research Training in Vascular Biology". The program provides MD trainees with a basic science/translational science curriculum, or a health services outcomes science curriculum. A great strength of the program is the cross fertilization between the two curricula with common elements of training for both pathways. Training is centered at the new North Campus Research Complex (NCRC) and at the University of Michigan Samuel and Jean Frankel Cardiovascular Center. The North Campus Research Complex is one-of-a-kind, with U-M resources and crucial scientific core facilities, NCRC's environment is specifically designed to foster collaboration and innovation. NCRC has 28 buildings comprising 2.1 million square feet of office, research and manufacturing space acquired from Pfizer in 2009. Opening in 2007 the Cardiovascular Center localizes all primary services included in the care and treatment of cardiovascular disease. Faculty for the program come from multiple disciplines including Vascular Surgery, General Surgery, Cardiac Surgery, Internal Medicine, Cardiovascular Medicine, Emergency Medicine, Human Genetics, and Pathology. There is a didactic component to the proposal, in addition to the trainee working intensely with individual scientists from the Program Faculty. The common thread in this program is the emphasis on the study of vascular biology and cardiovascular science with the ultimate goal to provide the next generation of leaders in academic vascular biology and cardiovascular science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Monocyte/Macrophage Role in Experimental Deep Vein Thrombosis Resolution and Vein Wall Injury
The Monocyte/Macrophage Role in Experimental Deep Vein Thrombosis Resolution and Vein Wall Injury
The Monocyte/Macrophage Role in Experimental Deep Vein Thrombosis Resolution and Vein Wall Injury
The Monocyte/Macrophage Role in Experimental Deep Vein Thrombosis Resolution and Vein Wall Injury
海外基金